Amanote Research
Register
Sign In
Use of the Anti HER-2/neu Antibody Herceptin in the Treatment of Human Breast Cancer: Biological Rationale and Clinical Results
Breast Cancer Research
- United Kingdom
doi 10.1186/bcr134
Full Text
Open PDF
Abstract
Available in
full text
Categories
Cancer Research
Oncology
Date
March 1, 2000
Authors
DJ Slamon
Publisher
Springer Science and Business Media LLC
Related search
Treatment of HER-2/neu Overexpressing Breast Cancer Xenograft Models With Trastuzumab (Herceptin) and Gefitinib (ZD1839): Drug Combination Effects on Tumor Growth, HER-2/neu and Epidermal Growth Factor Receptor Expression, and Viable Hypoxic Cell Fraction
Clinical Cancer Research
Cancer Research
Oncology
Hormone Receptors, Her-2/Neu and Chromosomal Aberrations in Breast Cancer
Medical Journal Armed Forces India
Medicine
Impact of Polysomy 17 on HER-2/neu Immunohistochemistry in Breast Carcinomas Without HER-2/neu Gene Amplification
Journal of Molecular Diagnostics
Forensic Medicine
Pathology
Molecular Medicine
Biological Rationale for a Patient-Specific Approach in the Treatment of Breast Cancer. Clinical Value of Novel Biomarkers of Breast Cancer
Tumors of female reproductive system
HER-2/neu Transcriptionally Activates Jab1 Expression via the AKT/ -Catenin Pathway in Breast Cancer Cells
Endocrine-Related Cancer
Cancer Research
Endocrinology
Oncology
Metabolism
Diabetes
Chemosensitization of HER-2/neu-overexpressing Human Breast Cancer Cells to Paclitaxel (Taxol) by Adenovirus Type 5 E1A
Oncogene
Cancer Research
Genetics
Molecular Biology
Changes in 2-Fluoro-2-Deoxy-D-Glucose Incorporation, Hexokinase Activity and Lactate Production by Breast Cancer Cells Responding to Treatment With the Anti-Her-2 Antibody Trastuzumab
Nuclear Medicine and Biology
Cancer Research
Nuclear Medicine
Radiology
Molecular Medicine
Imaging
Inhibition of Cell Growth and Induction of Apoptosis byAntrodia Camphoratain HER-2/neu-Overexpressing Breast Cancer Cells Through the Induction of ROS, Depletion of HER-2/neu, and Disruption of the PI3K/Akt Signaling Pathway
Evidence-based Complementary and Alternative Medicine
Alternative Medicine
Complementary
Immunohistochemical Evaluation of Her-2/Neu Overexpression in Breast Carcinoma in Mosul
Annals of the College of Medicine, Mosul
